Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 2 Interventional

Study Evaluating SCA-136 in Subjects With Acute Exacerbations of Schizophrenia

ClinicalTrials.gov ID: NCT00265551

Public ClinicalTrials.gov record NCT00265551. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Jun 25, 2026, 4:56 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Randomized, Double-Blind, Placebo-Controlled, Olanzapine-Referenced, Parallel Group Safety, Efficacy, and Tolerability Study of SCA-136 in Subjects With Acute Exacerbations of Schizophrenia

Study identification

NCT ID
NCT00265551
Recruitment status
Completed
Study type
Interventional
Phase
Phase 2
Lead sponsor
Wyeth is now a wholly owned subsidiary of Pfizer
Industry
Enrollment
300 participants

Conditions and interventions

Conditions

Interventions

  • SCA-136 (200 mg) Drug
  • SCA-136 (400 mg) Drug
  • olanzapine (15 mg) Drug
  • placebo Drug

Drug

Eligibility (public fields only)

Age range
18 Years to 65 Years
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Dec 31, 2005
Primary completion
Not listed
Completion
Dec 31, 2006
Last update posted
Dec 9, 2007

2006 – 2007

United States locations

U.S. sites
35
U.S. states
18
U.S. cities
32
Facility City State ZIP Site status
Not listed Little Rock Arkansas 72201
Not listed Cerritos California 90703
Not listed Costa Mesa California 92627
Not listed La Mesa California 91942
Not listed Oceanside California 92056
Not listed Paramount California 90723
Not listed Pico Rivera California 90660
Not listed Rosemead California 91770
Not listed San Diego California 92103
Not listed San Diego California 92123
Not listed Torrance California 90502
Not listed Middletown Connecticut 06457
Not listed Washington D.C. District of Columbia 20016
Not listed Fort Lauderdale Florida 33301
Not listed Kissimmee Florida 34741
Not listed North Miami Florida 33161
Not listed Hoffman Estates Illinois 60194
Not listed Indianapolis Indiana 46222
Not listed Lake Charles Louisiana 70601
Not listed Baltimore Maryland 21202
Not listed Rockville Maryland 20850
Not listed St Louis Missouri 63118
Not listed Willingboro New Jersey 08046
Not listed Cedarhurst New York 11516
Not listed Holliswood New York 11423
Not listed Chagrin Falls Ohio 44022
Not listed Cincinnati Ohio 45220
Not listed Cincinnati Ohio 45267
Not listed Oklahoma City Oklahoma 73103
Not listed Fort Washington Pennsylvania 19034
Not listed Memphis Tennessee 38117
Not listed Austin Texas 78729
Not listed Austin Texas 78756
Not listed DeSoto Texas 75115
Not listed Tacoma Washington 98493

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT00265551, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Dec 9, 2007 · Synced Jun 25, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT00265551 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →